Politiparty
Politiparty

118th Congress Health

S. 148: Stop STALLING Act

ReportedMar 1, 2023

  1. Introduced (completed)Jan 30, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Reported to Senate, Mar 1, 2023

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

8

Bipartisan support.

Who scored on this bill

26 points earned
  1. 1Amy Klobuchar D-MN SponsorDrew cross-party cosponsors, introduced, reported3 events+26
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Amy Klobuchar

History

  1. Jan 30, 2023Introduced in the Senate by Amy Klobuchar.
Show the full action history (5 actions)
  1. Mar 1, 2023Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
  2. Mar 1, 2023Placed on Senate Legislative Calendar under General Orders. Calendar No. 21.
  3. Feb 9, 2023Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Jan 30, 2023Introduced in Senate
  5. Jan 30, 2023Read twice and referred to the Committee on the Judiciary.